BLOG

Nadrich & Cohen Investigating Claims in UCLA Bacterial Outbreak


UCLA OutbreakThe maker of the medical endoscopes involved in the deadly bacterial outbreak at UCLA Medical Center is being investigated for possible violations of laws that ban improper payments to doctors and other customers. The Los Angeles Times reports that seven patients have reportedly been infected so far by the drug-resistant bacteria at UCLA’s Ronald Reagan Medical Center, and two of those patients have died. Nadrich & Cohen is currently investigating claims, and encourages anyone affected by this outbreak to contact our firm at (310) 826-8082.

The Origins of the Outbreak  

According to reports, the Justice Department has been investigating Olympus Corp. of Americas, the U.S. subsidiary of the controversial scope maker, since 2011. Medical officials believe that the deadly outbreak is linked to the scopes, and the FDA has warned hospitals and physicians that these scopes may have fueled the superbug outbreak. The scope is inserted down patients’ throats for the treatment of a wide variety of ailments, ranging from cancers to gallstones, and Olympus is the leading provider of scopes used for these procedures.

The Superbug

The drug-resistant bacteria at the center of the outbreak is called CRE, or carbapenem-resistant Enterobacteriaceae. The germ is highly resistant to most antibiotics, and can be fatal to as many as 50 percent of the people infected. At least five patients continue to receive treatment after the recent outbreak, and Ronald Reagan Medical Center has notified an additional 179 patients who may have been exposed to the bug between October 2014 and January 2015.

Why is Olympus Under Investigation?

A spokesperson for Olympus has said that the company is closely monitoring the situation, and that medical professionals are provided with instructions on how to properly reprocess and clean the scopes after each use. The company has not detailed the reasons for the federal investigation, but has confirmed that the DOJ is looking into possible violations of federal anti-kickback laws. These investigations often focus on the possibility of a drug or device maker unlawfully paying off physicians while promoting its products.

Have You Been Affected by the Recent Outbreak?

If you received an ERCP procedure at UCLA’s Ronald Reagan Medical Center between October 2014 and January 2015, you may have been exposed to the bacteria. Seek medical attention right away, and contact the legal experts at Nadrich & Cohen for a free consultation to discuss your options. You may be entitled to compensation.

Do I Have A Case?

We offer free consultation. No office visit required, we will get back to you within 24 hours.

  • This field is for validation purposes and should be left unchanged.

 

What can we do for you?

  • Answer your legal question.
  • Provide a Free Case Evaluation.
  • Schedule an appointment.

 

Why
Choose Us?

  • Available 24/7
  • Trusted Since 1990
  • Local to You
  • Recovered $350,000,000
  • 5 Star Reviews
  • Free Case Evaluation
  • VIP Service
  • No Win, No Fee

Latest Law Post


March 15, 2019

Expert Testifies Before House Subcommittee Regarding Talc Use And Ovarian Cancer Link

A United States House of Representatives subcommittee, on March 12th, 2019, looked into whether they should give the Food and Drug Administration (FDA) the power to more strictly regulate cosmetics, including talcum powder and products containing talc.


March 13, 2019

IVC Filters Used for Blood Clots Come With Risks, Complications

 

We are Personal Injury Lawyers representing accident victims throughout California.
For 30 years, the law firm of Nadrich & Cohen, LLP has helped injury victims
obtain the compensation they deserve.